Register for your FREE account now and join the thousands of healthcare professionals who have depended on us for over 26 years for accurate, concise, and timely drug information.

Keep me logged in Forgot your password?

Please wait...

Please wait...

Pediatric Drug News

Levemir Expands Pediatric Indication

May 22, 2012

Novo Nordisk announced that the FDA has approved Levemir (insulin detemir [rDNA origin] injection) for use in children ages two to five years with type 1 diabetes.
 

Isentress Receives New Labeling Update

May 21, 2012

Merck announced that the FDA has approved a labeling update for Isentress (raltegravir) tablets to include 156-week data from the STARTMRK study.
 

Dr. Reddy's Launches OTC Lansoprazole

May 21, 2012

Dr. Reddy's Laboratories announced the launch of over-the-counter (OTC) Lansoprazole delayed-release capsules, the generic version of Novartis's Prevacid 24hr capsules.
 

New Product of the Week

DUTOPROL

5/21/2012

Pharmacological Class: Cardioselective β1-blocker + diuretic.
Active Ingredient(s): Metoprolol succinate extended-release, hydrochlorothiazide; 25/12.5mg, 50/12.5mg, 100/12.5mg; tablets.
Indication: Hypertension.
 

Pediatric News from Healthday

Daily Pediatric News

Conference News

Round-up

Pediatric Courses on mycme.com

Calculator

GFR for Children Calculator

A calculator for determining glomeruler filtration rate (GFR) in children using the Schwartz formula.
 
Click here for a full listing of calculators.

Clin. Challenge

Drastic weight loss and bone deformities in a breastfed infant

Ami Goldstein, MSN, CNM, FNP May 01, 2010

Could the mother's religious custom of wearing a full veil at all times have played a role in the child's illness?
 

ClinicalJobAdvisor

Loading...

More Jobs

ClinicalJobAdvisor

Loading...

More Jobs

© 2012 Haymarket Media, Inc.

This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization.

Your use of this website constitutes acceptance of Haymarket Media's Privacy Policy and Terms & Conditions